RaphaelStrickerMD

Internal Medicine • San Francisco, CA

Adult Clinical & Laboratory Immunology, Women's Health, Hematology/Oncology

Union Square Medical Associates

Join to view full profile

Dr. Stricker is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Stricker's full profile

Already have an account?

Office
595 Buckingham Way
Rm 350
San Francisco, CA 94132
Phone+1 415-399-1035

Fax+1 415-399-1057

Summary

Raphael Stricker, MD, is an internal medicine specialist based in San Francisco, CA, with subspecialties in adult clinical and laboratory immunology, reproductive immunology, and hematology/oncology. He completed his medical education at Columbia University and further trained at the University of Lausanne and University of California (San Francisco). Dr. Stricker serves as a medical director at Union Square Medical Associates and the Alan E. Beer Medical Center for Reproductive Immunology. His clinical expertise includes Lyme disease, tick-borne coinfections, reproductive immunology, and antiviral therapeutics. Dr. Stricker has published research on subjects such as tick-borne diseases, treatment of recurrent miscarriages, and COVID-19 therapeutics. He has received several accolades, including the Patients’ Choice Physician Award and the American Medical Association Physician’s Recognition Award.

Education & Training

University of California San Francisco School of MedicinePost-Doctoral Fellowship, 1984 - 1985
University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 1981 - 1984
Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 1978 - 1981
Columbia University Vagelos College of Physicians and SurgeonsClass of 1978
University of Lausanne Medical SchoolDiploma, 1972 - 1975
Columbia CollegeBA, 1967 - 1971
Horace Mann High SchoolDiploma, 1961 - 1967

Certifications & Licensure

CA State Medical License 1981 - 2027
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

Patients’ Choice Physician Award (2008), 2011
2007-2010 American Medical Association Physician’s Recognition Award (2007), 2010
Outstanding Reviewer Award Annals of Internal Medicine, 2008
American Medical Association Physician’s Recognition Award (2003), 2006
American Medical Association Physician’s Recognition Award (1999), 2002
San Francisco Magazine “500 Best Doctors” Award 2001
DATA Research Grant (1994), 1996
Elizabeth Reed Taylor Foundation Grant (1989), 1994
California Pacific Medical Center Grant 91-030 (1991), 1993
Children's Hospital of San Francisco Grant 90-041 (1990), 1993
Children's Hospital of San Francisco Grant 89-023 (1989), 1992
AIDS Investigator Award K87SF057 California State Task Force on AIDS (1987), 1989
NIH RO1 AI/HL 24288 National Heart, Lung and Blood Institute/National Institute of Allergy and Infectious Diseases (1987), 1989
AIDS Clinical Research Grant University of California San Francisco (1986), 1989
Academic Senate Research Grant University of California San Francisco (1986), 1987
Research Fellowship, 86-N37A American Heart Association, California Affiliate (1986), 1987
Research Fellowship, 85-N27A American Heart Association, California Affiliate (1985), 1986
Individual NRSA #1F32 HL-06871-01 CLN National Heart, Lung and Blood Institute (1984), 1985
NIH Research Grant #HL-07100-08 454965-31779 University of California Medical Center, San Francisco, CA (1982), 1984
Honors in Medicine, Neurology, and Psychiatry Columbia University College of Physicians and Surgeons (1975), 1978
Dean's List Columbia College (1968), 1971
Cum Laude Society Horace Mann Chapter, 1967
Medical Honors University of Lausanne Medical School (1972)
Join now to see all

Publications & Presentations

PubMed

Optimizing Exclusion Criteria for Clinical Trials of Persistent Lyme Disease Using Real-World Data.
Lorraine Johnson, Mira Shapiro, Deanna Needell, Raphael B Stricker
Healthcare. 2024-12-25
6 citations
Does Biological Sex Matter in Lyme Disease? The Need for Sex-Disaggregated Data in Persistent Illness.
Lorraine Johnson, Mira Shapiro, Sylvia Janicki, Jennifer Mankoff, Raphael B Stricker
International Journal of General Medicine. 2023-01-01
Role of hydroxychloroquine in multidrug treatment of COVID-19.
Peter A. McCullough, Raphael B Stricker, Harvey A. Risch
Reviews in Cardiovascular Medicine. 2021-09-24

Journal Articles

What about plasma?
Stricker RB, Arch Intern Med
Health care access and burden of care for patients with Lyme disease: A large United States survey.
Johnson L, Aylward A, Stricker RB, Health Policy
Benefit of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease.
Stricker RB, Green CL, Savely VR, Chamallas SN, Johnson L, Int J Gen Med
Neisseria subflava endophthalmitis.
Stricker RB, Pompilio JK, Axelrod JL, Kochman RS, Newton JC, Am J Ophthal
Pernicious anemia, 18q deletion syndrome, and IgA deficiency.
Stricker RB, Linker CA, JAMA
Hematologic malignancy in sickle cell disease.
Stricker RB, Embury SH, Am J Hematol
Intracranial bleeding during treatment with hydroxyethyl starch.
Damon L, Adams M, Stricker RB, Ries CA, N Engl J Med
Association of hematologic malignancies with hemoglobinopathies.
Stricker RB, Am J Hematol
Antibodies to thrombin in postsurgical patients.
Stricker RB, Corash L, Blood
CD8 T cells in human immunodeficiency virus infection.
Stricker RB, Arch Int Med
Autoantibody in post-transfusion purpura.
Stricker RB, Vox Sang
Polio vaccines and the origin of AIDS.
Elswood BF, Stricker RB, Res Virol
Polio vaccines and the origin of AIDS: Clarification.
Elswood BF, Stricker RB, Medical Hypotheses
Safety of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease.
Stricker RB, Green CL, Savely VR, Chamallas SN, Johnson L, Minerva Med
Make peer review really anonymous.
Stricker RB, Goldberg B, J NIH Res
Polio vaccines and the origin of AIDS: An update.
Stricker RB, Elswood BF, Medical Hypotheses
Time for change at journals.
Stricker RB, Goldberg B, J NIH Res
Time for peer review reform.
Stricker RB, Goldberg B, The Scientist
Viagra and HAART.
Stricker RB, Thomas DG, Brooks JP, South Med J
Intravenous immunoglobulin therapy for repeated failure of in-vitro fertilization.
Stricker RB, Steinleitner A, Fertil Steril
Carcinogenicity of statins.
Stricker RB, Goldberg B., South Med J
IDSA Lyme Guidelines: Response to Dr. Gershon's Letter.
Stricker RB, Johnson, L, South Med J
Antiphospholipid antibodies in patients with persistent Lyme disease symptoms.
Stricker RB, Johnson L, Lupus
Risk of malignancy associated with Lyme disease: Still up in the air.
Stricker RB, Johnson L, Int J Cancer
Clinical evidence for rapid transmission of Lyme disease following a tickbite: Response to Piesman and Gray.
Stricker RB, Hynote ED, Mervine P, . Diagn Microbiol Infect Dis
Join now to see all

Books/Book Chapters

Page 187 - 199Stricker RB, Steinleitner A, Winger EEClin Appl Immunol Rev
Page 133 - 134Stricker RBFuture Microbiol
Page 1 - 2Stricker RBMicrobe
Page 2 - 321Stricker RBMicrobe
Stricker RBHospital News
Page 1 - 51Stricker RB, Johnson LMicrobe
Phillips SE, Burrascano JJ, Harris NS, Horowitz R, Smith HA, Stricker RBCape Cod Times
Page 71 - 157Goldberg B, Stricker RBASM News
Page 70 - 347Stricker RB, Goldberg BASM News
Page 1 - 70Stricker RBASM News
Phillips SE, Bransfield R, Sherr VT, Smith HA, Dickson K, Stricker RB
Page 69 - 265Stricker RBLyme disease: A potential polymicrobial infection.
Page 89 - 96Mitsuyasu RT, Stricker RB, Gaynor R.American Society of Hematology
Page 60 - 62Stricker RBLyme Times
Page 76 - 491Stricker RBQuart Rev Biol
Page 45 - 48Stricker RBLyme Times
Page 40 - 41Stricker RBLyme Times
Page 117 - 121Epstein WL, Stricker RBAm J Contact Dermatitis
Page 277 - 282Kiprov DD, Miller RG, Stricker RBTherapeutic Plasmapheresis
Page 249 - 265Stricker RBHematol Oncol Clin North Am
Page 345 - 359Stricker RB, Kiprov DDEditors: Imbach P.Academic Press
Page 1 - 10Stricker RB, Kwiatkowska BJ, Miller RG, Kiprov DDEditors: Jaeger H (ed), Landsberg AL.
Page 95 - 114Stricker RBEditors: Volberding P, Jacobson MA.Marcel Dekker, New York
Join now to see all

Abstracts/Posters

Improved cellular immune function associated with topical dinitrochlorobenzene (DNCB) therapy in HIV disease.
Stricker RB, Goldberg B, Winger EE, Epstein WL, Clin Immunol
Human monoclonal cell surface-reactive autoantibodies: An initial characterization of reactivity and specificity.
Posner MR, Elboim HS, Tumber MB, Stricker RB, SBT Proceedings
Quantitation of HIV-1 RNA in plasma of asymptomatic, ARC and AIDS patients.
Zhu YS, Stricker RB, Gong Y, Kiprov DD, Isaacs S, Cimino G, VIII International Conference on AIDS, Amsterdam, Holland
Treatment of HIV neuropathy with plasmapheresis and intravenous gammaglobulin.
Kiprov DD, Stricker RB, Miller RG, VIII International Conference on AIDS, Amsterdam, Holland
A controlled study of lymphocyte immunization in recurrent spontaneous abortion (RSA): The role of antilymphocyte antibodies (ALA).
Kiprov D, Stricker R, Nachtigall R, Main E, Smith S, Dumlao C, Jacobson A, Garovoy M, Levinson C, Riv Immunol Immunofarm
Intravenous gammaglobulin (IVIG) treatment of recurrent spontaneous abortion (RSA) associated with combined alloimmune and autoimmune abnormalities.
Kiprov D, Stricker R, Nachtigall R, Main E, Smith S, Dumlao C, Jacobson A, Garovoy M, Levinson C, Riv Immunol Immunofarm
Analysis of lymphocyte subsets in HIV-infected patients treated with dinitrochlorobenzene (DNCB).
Stricker RB, Elswood BF, Goldberg B, Dumlao C, Van Elk J, Berger TG, Epstein WL, IX International Conference on AIDS, Berlin, Germany
Response to plasmapheresis following failure of intravenous gammaglobulin in patients with myasthenia gravis and Guillain-Barre syndrome.
Stricker RB, Kwiatkowska BJ, Habis JA, McLeod DE, Kiprov DD, J Clin Apheresis
Thrombotic microangiopathy complicating renal carcinoma: Report of the first two cases.
Stricker RB, Minor DR, Kiprov DD, J Clin Apheresis
Intravenous gammaglobulin (IVIG) treatment of recurrent spontaneous abortion (RSA) associated with combined alloimmune and autoimmune abnormalities.
Kiprov D, Stricker R, Nachtigall R, Main E, Smith S, Dumlao C, Jacobson A, Garovoy M, Levinson C, J Immunol
Clinical and immunologic monitoring of HIV-infected patients treated with topical dinitrochlorobenzene (DNCB).
Stricker RB, Elswood BF, Goldberg B, Henry J, Winger EE, Epstein WL, Tenth International Conference on AIDS, Yokohama, Japan
Potential benefit of repeated plasma donation in asymptomatic HIV-infected individuals.
Stricker RB, Youvan TD, McGrath MF, Levy J, J Clin Apheresis
Potential benefit of repeated plasma donation in asymptomatic HIV-infected individuals with decreased CD4 T-cell counts.
Stricker RB, Youvan TD, McGrath MF, Levy J, J Invest Med
Combination antiretroviral therapy and topical immune modulation with dinitrochlorobenzene (DNCB) in HIV disease.
Stricker RB, Goldberg B, Epstein WL, Blood
Clinical, immunologic and virologic effects of highly active antiretroviral therapy (HAART) combined with topical dinitrochlorobenzene (DNCB) in HIV disease.
Stricker RB, Goldberg B, Winger EE, Epstein WL, 12th World AIDS Conference, Geneva, Switzerland
Pathogenic considerations and prognostic factors in thrombotic thrombocytopenic purpura (TTP).
Stricker RB, Kiprov DD, J Clin Apheresis
Decreased CD57 lymphocyte subset in patients with chronic Lyme disease.
Stricker RB, Winger EE, FASEB J
Decreased CD57 lymphocyte subset in patients with chronic Lyme disease.
Stricker RB, Winger EE, Blood
Update and critical analysis of low-dose intravenous immunoglobulin (IVIG) therapy for immunologic abortion.
Stricker RB, Steinleitner A, Bookoff CN, Winger EE., Clin Immunol
. Critical analysis of intravenous immunoglobulin (IVIG) therapy for recurrent spontaneous abortion.
Stricker RB, Steinleitner A, Bookoff CN, Winger EE, Am J Reprod Immunol
Normalization of the CD57 natural killer cell subset associated wth prolonged antibiotic therapy in patients with chronic Lyme disease.
Stricker RB, Winger EE, Clin Immunol
Clinical and seroepidemiologic characteristics of Babesia WA-1 coinfection in patients with Lyme disease in California.
Stricker RB, Harris NS, Yong DC, Winger EE, J Invest Med
Clinical and immunologic evidence for transmission of Lyme disease through intimate human contact.
Stricker RB, Moore DH, Winger EE, J Invest Med
Prognostic significance of very low CD57 natural killer cells in patients with chronic Lyme disease.
Stricker RB, Winger EE, Clin Invest Med
Efficacy of clarithromycin/cefdinir combination therapy in patients with chronic Lyme disease.
Stricker RB, Thomas SL, Moore DH, Winger EE, J Invest Med
Join now to see all

Other

State of the art: Lyme disease and the legacy of Paul Ehrlich.
Stricker RB, Lautin A, Burrascano JJ, Proceedings of the World Ehrlich Conference on Antimicrobial Therapy
http://www.ehrlich2004.org/index.html
Nurenberg, Germany
Appropriateness of Lyme disease testing: An appropriate analysis?
Stricker RB, Hall PD, Lautin A, Ann Fam Med
http://www.annfammed.org/cgi/eletters/2/4/341#1049
Recognizing Lyme.
Stricker RB, New York Times
http://www.nytimes.com/
Medical revisionists threaten effective Lyme treatment.
Stricker RB, Hartford Courant
http://www.courant.com/
Consumer acceptance depends on whether guidelines reflect patient values.
Johnson L, Stricker R, Health Affairs blog
http://content.healthaffairs.org/content/29/7/1400/reply
Join now to see all

Press Mentions

Study Shows 90% of Persistent Lyme Patients Excluded from Clinical TrialsJanuary 7th, 2025
More Than 1,000 Scientists and Physicians Protest Specialty Boards' Actions Against Dissenting PhysiciansSeptember 13th, 2022
Should We Really Worry About Ticks on L.A. Beaches, and What Can We Do to Stay Safe?June 8th, 2021
Join now to see all

Other Languages

French